Alcon公司提出每股30.75美元,以购买STAAR外科手术设备,将交易额提高到16亿美元。 Alcon raised its offer to $30.75 per share to acquire STAAR Surgical, boosting the deal to $1.6 billion.

Alcon Inc. 将购买STAAR外科公司的现金报价提高到每股30.75美元,使交易价值增加1.5亿美元,达到约16亿美元,因为在“go-shop”期间未能吸引竞争性投标。 Alcon Inc. has raised its cash offer to acquire STAAR Surgical Company to $30.75 per share, increasing the deal’s value by $150 million to approximately $1.6 billion, following a failed attempt to attract competing bids during a "go-shop" period. 该修正案于2025年12月9日生效,加强了最初的28.00美元的报价,并反映了Alcon对完成兼并的承诺。 兼并仍按计划进行,直至2026年初结束,但须经管理部门批准,股东表决改期至12月19日。 The amendment, effective December 9, 2025, boosts the original $28.00 offer and reflects Alcon’s commitment to completing the merger, which remains on track for early 2026 closure, subject to regulatory approval and shareholder vote rescheduled to December 19. 修订后的条件包括减少执行人员付款,预计第二年会增加Alcon的收入。 The revised terms include reduced executive payments and are expected to be accretive to Alcon’s earnings in the second year. STAAR的股票在新闻上上涨14%至26.75美元。 STAAR’s stock rose 14% to $26.75 on the news.